Antiviral Chewing Gum Cuts Risk of Certain Head and Neck Cancers to Almost Zero in New Study

Research from the University of Pennsylvania shows that antiviral and antibacterial chewing gums reduce the levels of three microbes known to be associated with oral cancer, paving the way for more effective and affordable therapies. Head and neck squamous cell carcinoma (HNSCC) is a common cancer that develops in the lining of the mouth and